Chandrabose Selvaraj

About

Dr. Chandrabose Selvaraj is a Bioinformatician with expertise in the microbial informatics. His expertise also includes the computational chemistry, Molecular modeling and Drug design. Dr. Chandrabose Selvaraj obtained his Ph.D. in Bioinformatics (2014), from the Department of Bioinformatics, Alagappa University, India. He Did his post-doctoral in International esteemed institutes that include Food and Drug Administration (USA), Central European Institute of Technology (CEITEC-Brno), Konkuk University (South Korea), Indian Institute of Technology-Mandi (India) and currently he is working as Professor, Bioinformatics Division, Department of Marine Biotechnology, AMET University, India. His work is dedicated to understanding molecular level interactions between the Pathogen and humans for chemical biology and drug discovery, to apply theoretical, biophysical methods using various Bioinformatics approaches along with few experimental validations.

Employment

• AMET University Professor
  2025 - Present
• Saveetha University Associate Professor
  2023 - 2025
• Arontier Co Ltd Senior Scientist
  2022 - 2023
• Alagappa University Senior Researcher
  2019 - 2022
• Masarykova Univerzita Research Specialist
  2018 - 2019
• Indian Institute of Technology Mandi Senior Project Scientist
  2017 - 2018
• U.S. Food and Drug Administration ORISE Fellow
  2016 - 2017
• Konkuk University Assistant Professor
  2015 - 2016
• Alagappa University Senior Research Fellow
  2012 - 2014
• Alagappa University Alagappa University Research Fellow
  2010 - 2012

Education

• Alagappa University Ph. D
  2010 - 2014
• Bharathiar University M. Sc
  2007 - 2009
• Madurai Kamaraj University B. Sc
  2004 - 2007

Projects & Funding

Projects & funding information is unavailable.

Publications (147)

• Chronic Study on the Environmentally Relevant Concentration of Cytotoxic Drug Cyclophosphamide on the Biochemical Responses of the Freshwater Mussel Lamellidens marginalis
  APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY 2026 DOI: 10.1007/S12010-026-05698-7
  +Save
• Multivariate optimization and computational insights for the effective decolorization of reactive orange 107 using Rhizoclonium hieroglyphicum and its sustainable reuse potential
  INTERNATIONAL JOURNAL OF PHYTOREMEDIATION 2026 DOI: 10.1080/15226514.2025.2579144
  +Save
• Pathogen-specific drug metabolism in tuberculosis: Enzymes, metabolic pathways, and new horizons in therapeutic development
  MICROBIAL PATHOGENESIS 2026 DOI: 10.1016/J.MICPATH.2025.108173
  +Save
• Phenytoin as an emerging pollutant on non-target aquatic invertebrates: effects on Lamellidens marginalis
  DRUG AND CHEMICAL TOXICOLOGY 2026 DOI: 10.1080/01480545.2025.2579543
  +Save
• Case Studies and Clinical Scenarios in NSCLC
  2025 DOI: 10.4018/979-8-3373-2096-0.ch007
  +Save
• Artificial intelligence in cancer care: revolutionizing diagnosis, treatment, and precision medicine amid emerging challenges and future opportunities
  3 Biotech 2025 DOI: 10.1007/s13205-025-04518-9
  +Save
• Advances in cancer therapy: unveil the immunomodulatory protein involved in signaling pathways as molecular targets
  Chemical Papers 2025 DOI: 10.1007/s11696-025-04007-6
  +Save
• Ecotoxicological effects of titanium dioxide nanoparticles on the freshwater mussel Lamellidens marginalis: physiological disruption, oxidative stress, and ecological implications
  Scientific Reports 2025 DOI: 10.1038/s41598-025-98715-4
  +Save
• Decoding pH-dependent structural dynamics of CHIKV nsP2 protease: insights from computational antiviral targeting
  MOLECULAR DIVERSITY 2025 DOI: 10.1007/S11030-025-11343-Y
  +Save
• Harnessing the human microbiome and its impact on immuno-oncology and nanotechnology for next-generation cancer therapies
  European Journal of Pharmacology 2025 DOI: 10.1016/j.ejphar.2025.177436
  +Save